2026年8月27日，锦欣生殖医疗集团有限公司（股票代码：01951）发布翌日披露报表，公告当日于香港联交所回购普通股2,627,000股，相当于回购前已发行股本（不包括库存股）约0.0971%。本次回购股份的最高价为每股2.35港元，最低价为每股2.245港元，平均价约为每股2.2835港元，合计付出约5,998,840港元（约599.88万港元）。回购完成后，公司已发行股本（不包括库存股）变动为2,702,380,543股，库存股约2,663,500股。
此外，公告显示，公司于2026年6月25日获股东大会通过购回授权，最多可回购262,511,954股（约2.63亿股），并已于香港联交所及其他证券交易所合计回购15,205,000股（约1,520.50万股），占该购回授权通过当日公司已发行股本（不包括库存股）约0.5792%。公司确认上述回购符合香港联合交易所有限公司证券上市规则及相关法规。公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.